Researchers unveil Fas-p53 axis as a key regulator in adipocyte metabolism, linking it to obesity and insulin sensitivity ...

Scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment innovation.

HPH-15, a novel compound, shows promise in treating Type 2 diabetes by reducing blood glucose levels and combating fat ...

In WT mice, rh-sCD14 led to increased insulin action. This improvement consistently ... and performed the HFD-based obese and diabetic mouse models. E.S. carried out the animal studies, analyzed ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...

Intraperitoneal injections of glucose (2g/kg for mice fed with a NCD and 1g/kg for mice fed with a HFD) or insulin (0.5U/kg for mice fed with a NCD and 1U/kg for mice fed with a HFD) were administered ...

(A-C) Glucose tolerance (GTT) and insulin tolerance ITT) were tested for female F0, F1, and F2, respectively. * p<0.05; ** p<0.01. (G) Inheritance of altered methylation in different generations was ...